Lecture on the immune system and new vaccines
[PRESS RELEASE 2011-03-11] Large-scale collaboration is being initiated between Karolinska Institutet and the renowned Rockefeller University in the US. This will begin with a visit from Professor Ralph Steinman, who has made crucial immunological discoveries of significance to diseases such as AIDS and cancer.
Journalists are welcome to attend the lecture Vaccines to mobilize dendritic cells . There will also be an opportunity to interview Professor Steinman.
- Time: Wednesday 23 March at 13:30-14:30
- Venue: Nobel Forum, Nobels väg 1, Karolinska Institutet, Solna Campus.
Professor Steinman is head of the Laboratory of Cellular Physiology and Immunology at the Rockefeller University. He discovered dendritic cells, a type of immune cell that captures antigens and presents them to other immune cells. Professor Steinman´s research focuses on understanding the development of immunological diseases and on designing new treatments and vaccines. In Stockholm, he will speak about subjects such as the latest developments in anti-HIV vaccination.
The lecture is part of a major new programme of collaboration between the Rockefeller University and Karolinska Institutet. The Rockefeller University is world-famous for its research and education within biomedical science, and has produced 23 Nobel Laureates. Later this year, Karolinska Institutet´s Professor Thomas Perlmann will travel to the US to give a lecture at the Rockefeller University. These lectures - the Nicholson Lectures - will then be held annually in the two countries.
In addition to these lectures, the collaboration also includes two other elements. A research exchange programme will enable selected researchers from one university to work at the other university for short periods of one to twelve weeks. There is also now an exchange programme for post-doctoral students. Those who have completed their doctoral education in Sweden will therefore be able to carry out research at the Rockefeller University for a period of up to two years. US researchers are also expected to come to Karolinska Institutet as part of the same programme.